BiotechTube
Home/DIVERCHIM CDMO/Sarah Delecrin
SD

Sarah Delecrin

QA and Regulatory Affairs Director

DIVERCHIM CDMO

Therapeutic Areas

Orphan Drugs/Rare DiseasesOncology (via Radiopharmaceuticals)Various (via CDMO services)

DIVERCHIM CDMO Pipeline

DrugIndicationPhase
PickASO ProjectTherapy to activate autophagy (via ASO)Pre-clinical/Development

Leadership Team at DIVERCHIM CDMO

FM
François Macarez
CEO
BF
Benoît Folléas
CSO, Head of Project Management
BD
Bruno Dudot
Head of Large Scale Production
FL
Fabien Lajus
Head of QC Lab. And Analytical Development
View full DIVERCHIM CDMO profile